These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Linezolid decreases susceptibility to secondary bacterial pneumonia postinfluenza infection in mice through its effects on IFN-γ. Breslow-Deckman JM; Mattingly CM; Birket SE; Hoskins SN; Ho TN; Garvy BA; Feola DJ J Immunol; 2013 Aug; 191(4):1792-9. PubMed ID: 23833238 [TBL] [Abstract][Full Text] [Related]
6. Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. Nakamura S; Davis KM; Weiser JN J Clin Invest; 2011 Sep; 121(9):3657-65. PubMed ID: 21841308 [TBL] [Abstract][Full Text] [Related]
7. IL-10 Counteracts IFN-γ to Alleviate Acute Lung Injury in a Viral-Bacterial Superinfection Model. McKelvey M; Uddin MB; Palani S; Shao S; Sun K Am J Respir Cell Mol Biol; 2024 Jul; 71(1):110-120. PubMed ID: 38574279 [TBL] [Abstract][Full Text] [Related]
8. IFN-γ Drives TNF-α Hyperproduction and Lethal Lung Inflammation during Antibiotic Treatment of Postinfluenza Verma AK; Bauer C; Palani S; Metzger DW; Sun K J Immunol; 2021 Sep; 207(5):1371-1376. PubMed ID: 34380647 [TBL] [Abstract][Full Text] [Related]
9. Immune predisposition drives susceptibility to pneumococcal pneumonia after mild influenza A virus infection in mice. Palani S; Uddin MB; McKelvey M; Shao S; Sun K Front Immunol; 2023; 14():1272920. PubMed ID: 37771584 [TBL] [Abstract][Full Text] [Related]
10. Type I Interferon Signaling Is a Common Factor Driving Streptococcus pneumoniae and Influenza A Virus Shedding and Transmission. Zangari T; Ortigoza MB; Lokken-Toyli KL; Weiser JN mBio; 2021 Feb; 12(1):. PubMed ID: 33593970 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-35 is upregulated in response to influenza virus infection and secondary bacterial pneumonia. Chen Y; Wang CJ; Lin SH; Zhang M; Li SY; Xu F Cytokine; 2016 May; 81():23-7. PubMed ID: 26844658 [TBL] [Abstract][Full Text] [Related]
12. Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection. Shepardson KM; Larson K; Morton RV; Prigge JR; Schmidt EE; Huber VC; Rynda-Apple A mBio; 2016 May; 7(3):. PubMed ID: 27143388 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Sun K; Metzger DW Nat Med; 2008 May; 14(5):558-64. PubMed ID: 18438414 [TBL] [Abstract][Full Text] [Related]
14. Regulation of IFN-γ by IL-13 dictates susceptibility to secondary postinfluenza MRSA pneumonia. Rynda-Apple A; Harmsen A; Erickson AS; Larson K; Morton RV; Richert LE; Harmsen AG Eur J Immunol; 2014 Nov; 44(11):3263-72. PubMed ID: 25091976 [TBL] [Abstract][Full Text] [Related]
15. Functional Interplay between Type I and II Interferons Is Essential to Limit Influenza A Virus-Induced Tissue Inflammation. Stifter SA; Bhattacharyya N; Pillay R; Flórido M; Triccas JA; Britton WJ; Feng CG PLoS Pathog; 2016 Jan; 12(1):e1005378. PubMed ID: 26731100 [TBL] [Abstract][Full Text] [Related]
16. Progranulin Decreases Susceptibility to Wang X; Yuan J; Wang H; Gan N; Zhang Q; Liu B; Wang J; Shu Z; Rao L; Gou X; Zhang H; Yin Y; Zhang X J Immunol; 2019 Oct; 203(8):2171-2182. PubMed ID: 31519865 [No Abstract] [Full Text] [Related]
17. Influenza a virus and Xiang L; Zhou TJ; Zhou LL; Luo J; Qin Z; You JZ; Jian J; Zhao ZY; Zhou YS; Ye YC; Wang HR; Wang BN; Li MY J Biol Regul Homeost Agents; 2019; 33(5):1437-1449. PubMed ID: 31637902 [TBL] [Abstract][Full Text] [Related]
18. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. Shahangian A; Chow EK; Tian X; Kang JR; Ghaffari A; Liu SY; Belperio JA; Cheng G; Deng JC J Clin Invest; 2009 Jul; 119(7):1910-20. PubMed ID: 19487810 [TBL] [Abstract][Full Text] [Related]
19. Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice. Lee B; Robinson KM; McHugh KJ; Scheller EV; Mandalapu S; Chen C; Di YP; Clay ME; Enelow RI; Dubin PJ; Alcorn JF Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(2):L158-67. PubMed ID: 26001778 [TBL] [Abstract][Full Text] [Related]
20. Exogenous Activation of Invariant Natural Killer T Cells by α-Galactosylceramide Reduces Pneumococcal Outgrowth and Dissemination Postinfluenza. Barthelemy A; Ivanov S; Hassane M; Fontaine J; Heurtault B; Frisch B; Faveeuw C; Paget C; Trottein F mBio; 2016 Nov; 7(6):. PubMed ID: 27803187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]